{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T04:55:58Z","timestamp":1789275358505,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T00:00:00Z","timestamp":1725321600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ajem.2024.08.036","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T17:59:10Z","timestamp":1725472750000},"page":"130-139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Tranq Dope: Characterization of an ED cohort treated with a novel opioid withdrawal protocol in the era of fentanyl\/xylazine"],"prefix":"10.1016","volume":"85","author":[{"given":"Kory","family":"London","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Kahoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davis","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamus","family":"Mulholland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Roque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Logan","family":"Stugart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Gillingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Borne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Slovis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajem.2024.08.036_bb0005","series-title":"US Overdose deaths in 2021 increased half as much as in 2020-but are still up 15%","first-page":"2022","volume":"16","author":"Control, C.f.D. and Prevention","year":"2022"},{"key":"10.1016\/j.ajem.2024.08.036_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108568","article-title":"Prevalence and charges of opioid-related visits to US emergency departments","volume":"221","author":"Langabeer","year":"2021","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.ajem.2024.08.036_bb0015","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.annemergmed.2021.04.023","article-title":"Consensus recommendations on the treatment of opioid use disorder in the emergency department","volume":"78","author":"Hawk","year":"2021","journal-title":"Ann. Emerg. Med."},{"issue":"11","key":"10.1016\/j.ajem.2024.08.036_bb0020","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/acem.14054","article-title":"Emergency department\u2013initiated interventions for patients with opioid use disorder: a systematic review","volume":"27","author":"Kaczorowski","year":"2020","journal-title":"Acad. Emerg. Med."},{"key":"10.1016\/j.ajem.2024.08.036_bb0025","series-title":"What should clinicians do as fentanyl replaces heroin?","author":"Bisaga","year":"2019"},{"issue":"1","key":"10.1016\/j.ajem.2024.08.036_bb0030","first-page":"140","article-title":"Changing landscape of fentanyl\/heroin use and distribution","volume":"53","author":"Pesce","year":"2023","journal-title":"Ann. Clin. Lab. Sci."},{"key":"10.1016\/j.ajem.2024.08.036_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103402","article-title":"Fentanyl epidemic hits the US West coast: opioid-related deaths in San Francisco from 2009\u20132019","volume":"95","author":"West","year":"2021","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.ajem.2024.08.036_bb0040","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s11524-011-9662-6","article-title":"The emerging of xylazine as a new drug of abuse and its health consequences among drug users in Puerto Rico","volume":"89","author":"Reyes","year":"2012","journal-title":"J. Urban Health"},{"key":"10.1016\/j.ajem.2024.08.036_bb0045","series-title":"Injection of Xylazine mixed with heroin associated with poor health outcomes and HIV risk behaviors in Puerto Rico. In Addiction Science & Clinical Practice","author":"L\u00f3pez","year":"2015"},{"key":"10.1016\/j.ajem.2024.08.036_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1747-597X-6-7","article-title":"Xylazine (veterinary sedative) use in Puerto Rico","volume":"6","author":"Torruella","year":"2011","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"1","key":"10.1016\/j.ajem.2024.08.036_bb0055","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12954-021-00581-6","article-title":"Acute pain and self-directed discharge among hospitalized patients with opioid-related diagnoses: a cohort study","volume":"18","author":"Compton","year":"2021","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.ajem.2024.08.036_bb0060","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jdcr.2023.04.016","article-title":"Severe cutaneous ulcerations secondary to xylazine (tranq): a case series","volume":"36","author":"Wei","year":"2023","journal-title":"JAAD Case Rep."},{"key":"10.1016\/j.ajem.2024.08.036_bb0065","author":"Education, T.C.F.F.S.R"},{"key":"10.1016\/j.ajem.2024.08.036_bb0070","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cca.2021.07.010","article-title":"High prevalence of xylazine among fentanyl screen-positive urines from hospitalized patients, Philadelphia, 2021","volume":"521","author":"Korn","year":"2021","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"10.1016\/j.ajem.2024.08.036_bb0075","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"10.1016\/j.ajem.2024.08.036_bb0080","series-title":"Takotsubo Cardiomyopathy in Xylazine Abuse and Polysubstance Withdrawal","author":"Shapses","year":"2024"},{"issue":"3","key":"10.1016\/j.ajem.2024.08.036_bb0085","article-title":"Xylazine in the opioid epidemic: a systematic review of case reports and clinical implications","volume":"15","author":"Ayub","year":"2023","journal-title":"Cureus"},{"issue":"24","key":"10.1016\/j.ajem.2024.08.036_bb0090","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMp2303120","article-title":"Xylazine\u2014medical and public health imperatives","volume":"388","author":"Gupta","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ajem.2024.08.036_bb0095","first-page":"10","article-title":"Research priorities to improve treatment of patients exposed to Xylazine-fentanyl: rapid communication from a National Institute on Drug Abuse Center for the clinical trials network meeting","author":"Haroz","year":"2023","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.ajem.2024.08.036_bb0100","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00213-012-2705-1","article-title":"Treatment of cocaine withdrawal anxiety with guanfacine: relationships to cocaine intake and reinstatement of cocaine seeking in rats","volume":"223","author":"Buffalari","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ajem.2024.08.036_bb0105","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00023210-200519010-00002","article-title":"Novel approaches to the treatment of cocaine addiction","volume":"19","author":"Sofuoglu","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ajem.2024.08.036_bb0110","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.drugalcdep.2016.10.015","article-title":"Treatment utilization among persons with opioid use disorder in the United States","volume":"169","author":"Wu","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ajem.2024.08.036_bb0115","author":"Philly"},{"key":"10.1016\/j.ajem.2024.08.036_bb0120","article-title":"Management of Xylazine Withdrawal in a patient admitted to the intensive care unit with carbon monoxide poisoning. C48. Case reports: Toxicology and other involving medications","author":"Boyce","year":"2023","journal-title":"American Thoracic Society"},{"issue":"5","key":"10.1016\/j.ajem.2024.08.036_bb0125","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/ADM.0000000000000955","article-title":"Management of xylazine withdrawal in a hospitalized patient: a case report","volume":"16","author":"Ehrman-Dupre","year":"2010","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.ajem.2024.08.036_bb0130","series-title":"NYS OASAS Medical Advisory Panel (MAP) Xylazine Guidance","author":"Hochul","year":"2024"},{"key":"10.1016\/j.ajem.2024.08.036_bb0135","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2147\/SAR.S433358","article-title":"Managing opioid withdrawal symptoms during the fentanyl crisis: a review","author":"Weber","year":"2024","journal-title":"Subst. Abus. Rehabil."},{"key":"10.1016\/j.ajem.2024.08.036_bb0140","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s11606-017-3993-2","article-title":"Emergency department-initiated buprenorphine for opioid dependence with continuation in primary care: outcomes during and after intervention","volume":"32","author":"D'Onofrio","year":"2017","journal-title":"J. Gen. Intern. Med."},{"issue":"16","key":"10.1016\/j.ajem.2024.08.036_bb0145","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1001\/jama.2015.3474","article-title":"Emergency department\u2013initiated buprenorphine\/naloxone treatment for opioid dependence: a randomized clinical trial","volume":"313","author":"D'Onofrio","year":"2015","journal-title":"Jama"},{"issue":"10","key":"10.1016\/j.ajem.2024.08.036_bb0150","doi-asserted-by":"crossref","first-page":"e2021209","DOI":"10.1001\/jamanetworkopen.2020.21209","article-title":"Trends in the use of buprenorphine in US emergency departments, 2002-2017","volume":"3","author":"Rhee","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"4","key":"10.1016\/j.ajem.2024.08.036_bb0155","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/ADM.0000000000000952","article-title":"A Plea from people who use drugs to clinicians: new ways to initiate buprenorphine are urgently needed in the fentanyl era","volume":"16","author":"Sue","year":"2022","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.ajem.2024.08.036_bb0160","author":"Brico"},{"issue":"6","key":"10.1016\/j.ajem.2024.08.036_bb0165","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1080\/15563650.2022.2032730","article-title":"Reddit discussions about buprenorphine associated precipitated withdrawal in the era of fentanyl","volume":"60","author":"Spadaro","year":"2022","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.ajem.2024.08.036_bb0170","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ajem.2022.05.013","article-title":"Buprenorphine precipitated opioid withdrawal: prevention and management in the ED setting","volume":"58","author":"Spadaro","year":"2022","journal-title":"Am. J. Emerg. Med."},{"issue":"4","key":"10.1016\/j.ajem.2024.08.036_bb0175","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/add.16100","article-title":"Fentanyl withdrawal: understanding symptom severity and exploring the role of body mass index on withdrawal symptoms and clearance","volume":"118","author":"Luba","year":"2023","journal-title":"Addiction"},{"key":"10.1016\/j.ajem.2024.08.036_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2022.108832","article-title":"Adapting methadone inductions to the fentanyl era","volume":"141","author":"Buresh","year":"2022","journal-title":"J. Subst. Abus. Treat."},{"issue":"2","key":"10.1016\/j.ajem.2024.08.036_bb0185","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1213\/01.ANE.0000118109.12855.07","article-title":"Ketamine as adjuvant analgesic to opioids: a quantitative and qualitative systematic review","volume":"99","author":"Subramaniam","year":"2004","journal-title":"Anesth. Analg."},{"issue":"10","key":"10.1016\/j.ajem.2024.08.036_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165461","article-title":"The effects of low-dose ketamine on acute pain in an emergency setting: a systematic review and meta-analysis","volume":"11","author":"Lee","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ajem.2024.08.036_bb0195","first-page":"277","article-title":"Efficacy of ketamine in the treatment of substance use disorders: a systematic review","volume":"9","author":"Jones","year":"2018","journal-title":"Front. Psychol."},{"issue":"4","key":"10.1016\/j.ajem.2024.08.036_bb0200","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jclinane.2004.08.010","article-title":"Morphine sparing with droperidol in patient-controlled analgesia","volume":"17","author":"Lo","year":"2005","journal-title":"J. Clin. Anesth."},{"issue":"3","key":"10.1016\/j.ajem.2024.08.036_bb0205","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jemermed.2022.12.012","article-title":"Droperidol use in the emergency department: a clinical review","volume":"64","author":"Siegel","year":"2023","journal-title":"J Emerg Med"},{"issue":"2","key":"10.1016\/j.ajem.2024.08.036_bb0210","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ajem.2005.08.017","article-title":"Antiemetics in the ED: a randomized controlled trial comparing 3 common agents","volume":"24","author":"Braude","year":"2006","journal-title":"Am. J. Emerg. Med."},{"issue":"4","key":"10.1016\/j.ajem.2024.08.036_bb0215","doi-asserted-by":"crossref","first-page":"728","DOI":"10.5811\/westjem.2020.4.47036","article-title":"The incidence of QT prolongation and torsades des pointes in patients receiving droperidol in an urban emergency department","volume":"21","author":"Cole","year":"2020","journal-title":"West. J. Emerg. Med."},{"issue":"4","key":"10.1016\/j.ajem.2024.08.036_bb0220","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1526-4637.2004.04054.x","article-title":"Do the second-generation \u201catypical neuroleptics\u201d have analgesic properties? A structured evidence-based review","volume":"5","author":"Fishbain","year":"2004","journal-title":"Pain Med."},{"issue":"8","key":"10.1016\/j.ajem.2024.08.036_bb0225","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1080\/15563650.2018.1547828","article-title":"An open-label randomized trial of intramuscular olanzapine versus oral clonidine for symptomatic treatment of opioid withdrawal in the emergency department","volume":"57","author":"Klein","year":"2019","journal-title":"Clin. Toxicol."},{"issue":"10241","key":"10.1016\/j.ajem.2024.08.036_bb0230","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/S0140-6736(20)30852-7","article-title":"New directions in the treatment of opioid withdrawal","volume":"395","author":"Srivastava","year":"2020","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ajem.2024.08.036_bb0235","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1080\/00952990.2017.1334209","article-title":"A novel non-opioid protocol for medically supervised opioid withdrawal and transition to antagonist treatment","volume":"44","author":"Rudolf","year":"2018","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"8","key":"10.1016\/j.ajem.2024.08.036_bb0240","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1177\/070674378703200807","article-title":"Treatment of heroin withdrawal with guanfacine: an open clinical investigation","volume":"32","author":"Soler Insa","year":"1987","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.ajem.2024.08.036_bb0245","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s40263-018-0572-y","article-title":"The cholinergic system as a treatment target for opioid use disorder","volume":"32","author":"Jensen","year":"2018","journal-title":"CNS Drugs"},{"issue":"6","key":"10.1016\/j.ajem.2024.08.036_bb0250","article-title":"Old drugs and new challenges: a narrative review of Nitazenes","volume":"15","author":"Pergolizzi","year":"2023","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.ajem.2024.08.036_bb0255","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1111\/1556-4029.15242","article-title":"Identification of the veterinary sedative medetomidine in combination with opioids and xylazine in Maryland","volume":"68","author":"Sisco","year":"2023","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.ajem.2024.08.036_bb0260","author":"Papsun"}],"updated-by":[{"DOI":"10.1016\/j.ajem.2024.10.006","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000}}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675724004303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675724004303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T04:12:46Z","timestamp":1730347966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675724004303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":52,"alternative-id":["S0735675724004303"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2024.08.036","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.ajem.2024.10.006","asserted-by":"object"}]},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tranq Dope: Characterization of an ED cohort treated with a novel opioid withdrawal protocol in the era of fentanyl\/xylazine","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2024.08.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}